Effect of lipophilicity at N-1 on activity of fluoroquinolones against mycobacteria

Related Experiment Videos

T E Renau1, J P Sanchez, M A Shapiro

  • 1Parke-Davis Pharmaceutical Research Division, Warner Lambert Company, Ann Arbor, Michigan 48105, USA.

Insights

Researchers explored how lipophilicity affects quinolone potency against drug-resistant Mycobacterium tuberculosis. Increased lipophilicity alone did not enhance antibacterial activity; intrinsic activity against other bacteria was the key factor.

Area of Science:

  • Medicinal Chemistry
  • Microbiology
  • Drug Discovery

Background:

  • Rising incidence of drug-resistant Mycobacterium tuberculosis necessitates novel antibacterial strategies.
  • Quinolone antibacterials are a focus for optimizing efficacy against mycobacteria.
  • N-1-phenyl substitution was investigated to modulate lipophilicity and potency.

Purpose of the Study:

  • To systematically synthesize and evaluate N-1-phenyl-substituted quinolone derivatives.
  • To determine the impact of increasing lipophilicity on antibacterial potency against mycobacteria.
  • To correlate compound activity with physicochemical properties like log P and pKa.

Main Methods:

  • Synthesis of N-1-phenyl-substituted quinolone derivatives via modified literature procedures.
  • Antimicrobial susceptibility testing against Gram-negative bacteria, Gram-positive bacteria, Mycobacterium fortuitum, and Mycobacterium smegmatis.
  • Correlation analysis of biological activity with physicochemical parameters (log P, pKa).

Main Results:

  • Increasing lipophilicity of N-1-phenyl substituents did not inherently increase potency against mycobacteria.
  • Antibacterial activity against Mycobacterium fortuitum (as a surrogate for M. tuberculosis) was not solely dependent on lipophilicity.
  • Intrinsic activity against Gram-negative and/or Gram-positive bacteria was identified as the primary determinant of antimycobacterial efficacy.

Conclusions:

  • Lipophilicity alone is not sufficient to enhance quinolone potency against Mycobacterium tuberculosis.
  • The antibacterial spectrum against common bacteria influences efficacy against mycobacteria.
  • Optimizing quinolones for mycobacterial infections requires consideration of broader antibacterial activity profiles.

Related Concept Videos